SOROS FUND MANAGEMENT LLC
Q1 2023 13F-HR Holdings
Net value change ($000)
-773,646
(-10.7%)
New positions
39
Sold out positions
40
Turnover %
37.2%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AWK | 46,349 | NEW |
| Horizon Therapeutics Public Ltd Co | 33,970 | 10.4% |
| IWM | 33,263 | NEW |
| AER | 30,107 | NEW |
| KWEB | 25,508 | NEW |
| EMXC | 22,692 | NEW |
| FSLY | 21,756 | NEW |
| TECK | 18,172 | NEW |
| KRE | 16,522 | NEW |
| NKE | 12,991 | 174.2% |
Top Reduces (Value $000, Stocks/ETFs)
| RIVN | -208,971 | -79.0% |
| Altra Industrial Motion Corp. | -119,500 | -100.0% |
| ARMK | -96,143 | -68.7% |
| Signify Health, Inc. | -80,978 | -100.0% |
| FHN | -79,169 | -37.9% |
| DHI | -61,744 | -100.0% |
| LUCK | -59,070 | -53.7% |
| CRM | -51,433 | -60.2% |
| IGSB | -49,820 | -100.0% |
| SPY | -41,267 | -89.8% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
1,226,301
(18.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|